Cibc World Markets Corp Blueprint Medicines Corp Transaction History
Cibc World Markets Corp
- $12.4 Billion
- Q1 2025
A detailed history of Cibc World Markets Corp transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Cibc World Markets Corp holds 14,109 shares of BPMC stock, worth $1.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,109
Previous 5,950
137.13%
Holding current value
$1.8 Million
Previous $518,000
140.93%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BPMC
# of Institutions
391Shares Held
68.5MCall Options Held
1.54MPut Options Held
1.08M-
Black Rock Inc. New York, NY6.65MShares$850 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.64MShares$849 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.42MShares$693 Million0.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.85MShares$492 Million5.51% of portfolio
-
Wellington Management Group LLP Boston, MA3.07MShares$393 Million0.05% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $7.64B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...